Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1b, Multicentre, Open Label, Study of the Efficacy, Safety and Tolerability of R131 Vaginal Ointment in Women with Cytological Abnormalities of the Uterine Cervix

Trial Profile

A Phase 1b, Multicentre, Open Label, Study of the Efficacy, Safety and Tolerability of R131 Vaginal Ointment in Women with Cytological Abnormalities of the Uterine Cervix

Not yet recruiting
Phase of Trial: Phase I/II

Latest Information Update: 25 Oct 2018

At a glance

  • Drugs Lopinavir/ritonavir (Primary)
  • Indications Cervical intraepithelial neoplasia
  • Focus Therapeutic Use
  • Sponsors Douglas Pharmaceuticals
  • Most Recent Events

    • 25 Oct 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top